Domain Interactions Determine the Amyloidogenicity of Antibody Light Chain Mutants

Benedikt Weber, Manuel Hora, Pamina Kazman, Tejaswini Pradhan, Florian Rührnößl, Bernd Reif, Johannes Buchner

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Abstract

In antibody light chain amyloidosis (AL), mutant light chains (LCs) or their variable domains (VLs) form fibrils, which accumulate in organs and lead to their failure. The molecular mechanism of this disease is still poorly understood. One of the key open issues is whether the mutant VLs and LCs differ in fibril formation. We addressed this question studying the effects of the VL mutations S20N and R61A within the isolated VL domain and in the full-length LC scaffold. Both VL variants readily form fibrils. Here, we find that in the LC context, the S20N variant is protected from fibril formation while for LC R61A fibril formation is even accelerated compared to VL R61A. Our analyses revealed that the partially unfolded state of the VL R61A domain destabilizes the CL domain by non-native interactions, in turn leading to a further unfolding of the VL domain. In contrast, the folded mutant VL S20N and VL wt form native interactions with CL. These are beneficial for LC stability and promote amyloid resistance. Thus the effects of specific mutations on the VL fold can have opposing effects on LC domain interactions, stability and amyloidogenicity.

Original languageEnglish
Pages (from-to)6187-6199
Number of pages13
JournalJournal of Molecular Biology
Volume432
Issue number23
DOIs
StatePublished - 20 Nov 2020

Keywords

  • AL amyloidosis
  • amyloid fibrils
  • antibody light chain
  • protein aggregation
  • protein stability

Fingerprint

Dive into the research topics of 'Domain Interactions Determine the Amyloidogenicity of Antibody Light Chain Mutants'. Together they form a unique fingerprint.

Cite this